EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The interplay between epitranscriptomic RNA modifications and neurodegenerative disorders: Mechanistic insights and potential therapeutic strategies

Muhammad Abu Talha Safdar Hashmi iD, Hooriya Fatima, Sadia Ahmad, Amna Rehman, Fiza Safdar

Ibrain · 2024-12 · 10 (4) · 395-426

DOI: 10.1002/ibra.12183 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ibrain, online erschienen am 11.11.2024. Verfasst von Muhammad Abu Talha Safdar Hashmi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology University of Central Punjab Lahore Pakistan. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 323 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative disorders encompass a group of age‐related conditions characterized by the gradual decline in both the structure and functionality of the central nervous system (CNS). RNA modifications, arising from the epitranscriptome or RNA‐modifying protein mutations, have recently been observed to contribute significantly to neurodegenerative disorders. Specific modifications like N6‐methyladenine (m6A), N1‐methyladenine (m1A), 5‐methylcytosine (m5C), pseudouridine and adenosine‐to‐inosine (A‐to‐I) play key roles, with their regulators serving as crucial therapeutic targets. These epitranscriptomic changes intricately control gene expression, influencing cellular functions and contributing to disease pathology. Dysregulation of RNA metabolism, affecting mRNA processing and noncoding RNA biogenesis, is a central factor in these diseases. This review underscores the complex relationship between RNA modifications and neurodegenerative disorders, emphasizing the influence of RNA modification and the epitranscriptome, exploring the function of RNA modification enzymes in neurodegenerative processes, investigating the functional consequences of RNA modifications within neurodegenerative pathways, and evaluating the potential therapeutic advancements derived from assessing the epitranscriptome.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer's diseaseParkinson's diseaseRNA modificationsepitranscriptomicsneurodegeneration

Autor:innen und Institutionen

  • Department of Zoology University of Central Punjab Lahore Pakistan.
  • Institute of Zoology University of Punjab Lahore Pakistan.
  • Department of Biochemistry University of Narowal Narowal Pakistan.

ORCID-Profile: Muhammad Abu Talha Safdar Hashmi

Zitieren

APA

Hashmi, M. A. T. S., Fatima, H., Ahmad, S., Rehman, A., & Safdar, F. (2024). The interplay between epitranscriptomic RNA modifications and neurodegenerative disorders: Mechanistic insights and potential therapeutic strategies. Ibrain, 10(4), 395-426. https://doi.org/10.1002/ibra.12183

Vancouver

Hashmi MATS, Fatima H, Ahmad S, Rehman A, Safdar F. The interplay between epitranscriptomic RNA modifications and neurodegenerative disorders: Mechanistic insights and potential therapeutic strategies. Ibrain. 2024;10(4):395-426. doi:10.1002/ibra.12183

BibTeX
@article{Hashmi2024,
  author = {Hashmi, Muhammad Abu Talha Safdar and Fatima, Hooriya and Ahmad, Sadia and Rehman, Amna and Safdar, Fiza},
  title = {The interplay between epitranscriptomic RNA modifications and neurodegenerative disorders: Mechanistic insights and potential therapeutic strategies},
  journal = {Ibrain},
  year = {2024},
  volume = {10},
  number = {4},
  pages = {395--426},
  doi = {10.1002/ibra.12183}
}
Kostenlos starten →